Genome & Company Market Cap

Genome & Company has a market cap or net worth of 90.43 billion as of November 18, 2024. Its market cap has decreased by -45.61% in one year.

Market Cap

90.43B

Enterprise Value

87.83B

Revenue

23.92B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,915.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 90.43B, an increase of 25.82%. That is a compound annual growth rate of 3.97%.

Market Cap History

Date	Market Cap	% Change
Nov 15, 2024	90.28B	-48.77%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	1,048.46B	224.28%
Dec 30, 2019	323.32B	241.20%
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition